CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 7294 result(s)

Public Health 2017

Event Date: June 6, 2017 - June 8, 2017
Result type: Events

CADTH is proud to be a “Friends of Public Health” sponsor of Public Health 2017, the annual conference of the Canadian Public Health Association (CPHA). Public Health 2017 is a national forum for public health professionals, researchers, policy-makers, academics, students and trainees to strengthen efforts to improve health and well-being,...

Apomorphine (Movapo)

Last Updated: April 18, 2018
Result type: Reports
Product Line: Reimbursement Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson's disease

  • Brand Name: Movapo
  • Manufacturer: Paladin Labs Inc.
  • Project Number: SR0527-000
  • Project Status: Complete
  • Submission Type: Initial

Evolocumab (Repatha)

Last Updated: June 7, 2017
Result type: Reports
Product Line: Reimbursement Review
Generic Name: Evolocumab
Indications: Primary hyperlipidemia and mixed dyslipidemia

  • Brand Name: Repatha
  • Manufacturer: Amgen Canada Inc.
  • Project Number: SR0515-000
  • Project Status: Complete
  • Submission Type: Resubmission

Northern, Rural, and Remote Health Conference

Event Date: October 6, 2017 - October 9, 2017
Result type: Events

Northern, Rural, and Remote Health Conference is an international forum dedicated to sharing knowledge, experience, and innovations in community health. This is a collaborative effort by health organizations in Labrador to promote and strengthen transdisciplinary dialogue on critical issues affecting the health and health care of rural, Nor...

sebelipase alfa (Kanuma)

Last Updated: November 27, 2018
Result type: Reports
Product Line: Reimbursement Review
Generic Name: sebelipase alfa
Indications: Lysosomal acid lipase deficiency

  • Brand Name: Kanuma
  • Manufacturer: Alexion Pharmaceuticals
  • Project Number: SR0544-000
  • Project Status: Complete
  • Submission Type: Initial